X0508 4 2023-07-18 0001958140 Atlanta Braves Holdings, Inc. BATRK 0001789667 Wilm Renee L 12300 LIBERTY BOULEVARD ENGLEWOOD CO 80112 1 Chief Legal/Admin Officer 0 Series C Common Stock 2023-07-18 4 J 0 5507.0000 0 A 5507.0000 D Series C Common Stock 2023-07-19 5 J 0 328.0000 0 A 5835.0000 D Stock Option (Right to Buy) - BATRK 27.7300 2023-07-18 5 J 0 34709.0000 A 2026-11-13 Series C Common Stock 34709.0000 34709.0000 D Stock Option (Right to Buy) - BATRK 26.3600 2023-07-18 5 J 0 6639.0000 A 2027-12-10 Series C Common Stock 6639.0000 6639.0000 D On July 18, 2023, Liberty Media Corporation ("Liberty Media") redeemed (the "Redemption") each share of its Liberty Braves common stock for shares of common stock of Atlanta Braves Holdings, Inc. (the "Issuer"). In the Redemption, Liberty Media redeemed (i) each outstanding share of its Series A Liberty Braves common stock for one share of the Issuer's Series A common stock, (ii) each outstanding share of its Series B Liberty Braves common stock for one share of the Issuer's Series B common stock and (iii) each outstanding share of its Series C Liberty Braves common stock for one share of the Issuer's Series C common stock. On July 19, 2023, following the Redemption, Liberty Media distributed on a pro rata basis 6,792,903 shares of the Issuer's Series C common stock to holders of Liberty Media's Series A Liberty Formula One common stock, Series B Liberty Formula One common stock and Series C Liberty Formula One common stock following the settlement and extinguishment of an intergroup interest in Liberty Media's Braves Group attributed to Liberty Media's Formula One Group, as described in the Registration Statement on Form S-4 filed by Liberty Media with the Securities and Exchange Commission (File No. 333-268921). In connection with the Redemption, all option awards held by reporting person with respect to Liberty Media's Liberty Braves common stock (each, a "Braves Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the option awards were granted, such that each Braves Award was exchanged for an option to purchase an equivalent number of shares of the corresponding series of the Issuer's common stock. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. This option award vested 50% on September 23, 2022 and will vest 50% on September 23, 2023. This option award vested 50% on December 10, 2022 and will vest 50% on December 10, 2023. /s/ Brittany A. Uthoff as Attorney-in-Fact for Renee L. Wilm 2023-07-20